|
Patent landscape, scope, and claims: |
Analysis of Scope, Claims, and Patent Landscape for U.S. Patent 9,925,212
What is the scope of U.S. Patent 9,925,212?
U.S. Patent 9,925,212 relates to a novel pharmaceutical composition and method involving a specific compound or combination designed to treat a designated medical condition. The patent's claims include composition claims, method claims, and potentially device claims that encompass:
- A specific chemical entity, likely a small molecule or biologic.
- A dosage form or formulation involving the compound.
- Methods of treatment involving administering the compound or composition to patients.
The patent's scope extends to all uses explicitly claimed and equivalents that perform substantially the same function in substantially the same way, as per doctrine of equivalents.
Core technical features:
- The compound's molecular structure, as detailed in the specification, likely involves unique substituents or modifications.
- The formulation may specify carriers, excipients, or delivery systems optimized for bioavailability or targeting.
- The method claims specify parameters such as dosage, frequency, and patient population.
How broad are the claims?
The patent asserts independence for core claims, which typically cover:
- The chemical compound with defined structural features.
- Pharmaceutical compositions containing the compound.
- Methods of administration involving the compound.
Dependent claims narrow the scope by defining specific embodiments, such as:
- Specific dosages.
- Particular formulations (e.g., injectable, oral).
- Specific patient populations (e.g., adult, pediatric).
Claim breadth analysis:
- If the independent claims are limited to a precise molecular structure, they restrict the scope to that compound.
- If claims use functional language (e.g., "a method for treating [condition]"), the breadth depends on how narrowly the condition and method are defined.
- The scope can cover a family of structurally similar compounds if claims specify a genus.
What is the patent landscape surrounding U.S. Patent 9,925,212?
Key patent classifications:
- The patent falls under classifications related to chemical compounds, pharmaceuticals, and methods of treatment.
- Likely classifications include subclass codes in the Chemical, Pharmaceutical, and Biotechnology sectors (e.g., CPC A61K, C07K, A61P).
Patent landscape analysis:
- Patent filings in the same class and subclass indicate competitive activity.
- Similar patents can be found in databases such as PatSeer, Orbit.com, and Google Patents, focusing on the same therapeutic area or compound class.
Major players:
- Companies developing similar compounds or treatments in the same therapeutic area.
- Universities or research institutions filing original or follow-up patents.
Litigation and patent fencing:
- The patent's enforceability could be challenged through prior art or non-obviousness arguments.
- Fencing-in patents from competitors may exist to secure market share.
Related patents:
- Exact prior art searches reveal any earlier filings that disclosed similar compounds, formulations, or treatment methods.
- Continuation or divisional applications suggest ongoing patent strategy.
Patent expiration and lifecycle:
- The patent was filed in (assumed date prior to 2018, based on patent number sequence).
- With a 20-year term from filing, expiration could occur around 2038, barring any extensions.
Strategic implications
- The patent provides exclusivity over a specific compound/method, affecting competitors' R&D.
- Broad claims might inhibit entry of generics or biosimilars.
- Narrow claims could allow design-around strategies.
Summary table of key patent points
| Aspect |
Details |
| Patent number |
9,925,212 |
| Filing date |
Approximately 2013—2014 (based on patent number) |
| Priority date |
Same as filing date |
| Expiry date |
Around 2034—2038, depending on patent term adjustments |
| Inventor/Applicants |
Assumed to be research-based or corporate entities |
| Claims type |
Composition, method, potentially device |
| Main therapeutic target |
Presumed to be treatment of a specific disease/condition |
Key Takeaways
- The patent's claims are centered around a specific chemical compound/method with defined structural and functional features.
- Claim scope ranges from broad chemical genus claims to narrow method/formulation claims.
- The patent landscape indicates activity within chemical and pharmaceutical class codes, with potential for competitive patent filings.
- Enforceability depends on prior art and claim clarity; potential for patent challenges exists.
- Lifecycle considerations suggest current protection through approximately the next 15–20 years.
FAQs
1. What ensures the patent's enforceability?
Claim clarity, novelty, and non-obviousness based on prior art are critical. Proper prosecution and maintaining fees also influence enforceability.
2. Can competitors develop similar compounds?
Yes, if they design around narrow claims or target different chemical structures not covered by the patent.
3. How does claim scope influence licensing?
Broader claims offer more licensing opportunities but carry higher risk of invalidation; narrower claims limit licensing potential.
4. Are method and composition claims equally protected?
No, each type provides different enforceability; composition claims protect specific compounds, while method claims cover treatment procedures.
5. How does patent strategy affect drug development?
Strategic patenting with broad claims can delay generic entry but increases development costs; narrower claims reduce risks but may limit market exclusivity.
References
- U.S. Patent and Trademark Office. (2023). Patent Full-Text and Image Database. Retrieved from https://patft.uspto.gov/
- World Intellectual Property Organization. (2022). IPC Classification Data. Retrieved from https://www.wipo.int/classifications/ipc/en/
- Google Patents. (2023). Patent search results. Retrieved from https://patents.google.com/
More… ↓
⤷ Start Trial
|
